Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP881020.RA_ixQE77AhSbSuGA3Mm7dO-mYiNcW_SBRSsFF3f4NdCM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP881020.RA_ixQE77AhSbSuGA3Mm7dO-mYiNcW_SBRSsFF3f4NdCM130_assertion type Assertion NP881020.RA_ixQE77AhSbSuGA3Mm7dO-mYiNcW_SBRSsFF3f4NdCM130_head.
- NP881020.RA_ixQE77AhSbSuGA3Mm7dO-mYiNcW_SBRSsFF3f4NdCM130_assertion description "[Combining somatic RET analysis with Ki-67 assessment seems to be useful for increasing the specificity of Ki-67 assessment alone and identifying patients with a more aggressive cancer: in our series, only the patients who died during the follow-up had both a somatic RET mutation and a Ki-67 expression level >50?cells/mm(2).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP881020.RA_ixQE77AhSbSuGA3Mm7dO-mYiNcW_SBRSsFF3f4NdCM130_provenance.
- NP881020.RA_ixQE77AhSbSuGA3Mm7dO-mYiNcW_SBRSsFF3f4NdCM130_assertion evidence source_evidence_literature NP881020.RA_ixQE77AhSbSuGA3Mm7dO-mYiNcW_SBRSsFF3f4NdCM130_provenance.
- NP881020.RA_ixQE77AhSbSuGA3Mm7dO-mYiNcW_SBRSsFF3f4NdCM130_assertion SIO_000772 21422198 NP881020.RA_ixQE77AhSbSuGA3Mm7dO-mYiNcW_SBRSsFF3f4NdCM130_provenance.
- NP881020.RA_ixQE77AhSbSuGA3Mm7dO-mYiNcW_SBRSsFF3f4NdCM130_assertion wasDerivedFrom befree-2016 NP881020.RA_ixQE77AhSbSuGA3Mm7dO-mYiNcW_SBRSsFF3f4NdCM130_provenance.
- NP881020.RA_ixQE77AhSbSuGA3Mm7dO-mYiNcW_SBRSsFF3f4NdCM130_assertion wasGeneratedBy ECO_0000203 NP881020.RA_ixQE77AhSbSuGA3Mm7dO-mYiNcW_SBRSsFF3f4NdCM130_provenance.